Advertisement

Topics

Biopharma, Regulators and Researchers Turn Their Focus to Universal Flu Vaccines

20:00 EDT 16 May 2018 | BioSpace

The 2017/2018 influenza season was considered one of the worst, made more so by the ineffectiveness of the season’s flu vaccine. The FDA is focusing partially on simply determining why this year’s flu vaccine missed the mark.

Original Article: Biopharma, Regulators and Researchers Turn Their Focus to Universal Flu Vaccines

NEXT ARTICLE

More From BioPortfolio on "Biopharma, Regulators and Researchers Turn Their Focus to Universal Flu Vaccines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Swine Flu - H1N1 influenza - H7N9
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of virus). The H1N1 flu virus will be one of the main vi...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...